These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10784375)

  • 1. The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty.
    Capanni M; Prisco D; Antonucci E; Chiarugi L; Boddi V; Abbate R; Giglioli C; Dabizzi RP; Margheri M; Simonetti I; Gensini GF
    Int J Clin Lab Res; 1999; 29(4):145-9. PubMed ID: 10784375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty.
    Ellis SG; Tcheng JE; Navetta FI; Muller DW; Weisman HF; Smith C; Anderson KM; Califf RM; Topol EJ
    Coron Artery Dis; 1993 Feb; 4(2):167-75. PubMed ID: 8269208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after successful percutaneous transluminal coronary angioplasty.
    Klein LW; Rosenblum J
    Prog Cardiovasc Dis; 1990; 32(5):365-82. PubMed ID: 2179996
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual platelet function under acetylsalicylic acid and the risk of restenosis after coronary angioplasty.
    Terres W; Hamm CW; Ruchelka A; Weilepp A; Kupper W
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):190-3. PubMed ID: 1376787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
    Bauters C; Mc Fadden EP; Lablanche JM; Quandalle P; Bertrand ME
    Circulation; 1993 Sep; 88(3):969-74. PubMed ID: 8353924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty.
    Konstantopoulos K; Kamat SG; Schafer AI; Bañez EI; Jordan R; Kleiman NS; Hellums JD
    Circulation; 1995 Mar; 91(5):1427-31. PubMed ID: 7867183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty].
    Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T
    J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Take S; Matsutani M; Ueda H; Hamaguchi H; Konishi H; Baba Y; Kawaratani H; Sugiura T; Iwasaka T; Inada M
    Am J Cardiol; 1997 Apr; 79(8):1097-9. PubMed ID: 9114771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA.
    van de Loo A; Nauck M; Noory E; Just H; Wollschläger H
    Eur Heart J; 1998 Jan; 19(1):96-102. PubMed ID: 9503181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty.
    Bach R; Jung F; Kohsiek I; Ozbek C; Spitzer S; Scheller B; Dyckmans J; Schieffer H
    Thromb Res; 1994; 74 Suppl 1():S55-67. PubMed ID: 8073402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
    Gibson CM; Goel M; Cohen DJ; Piana RN; Deckelbaum LI; Harris KE; King SB
    J Am Coll Cardiol; 1998 Jul; 32(1):28-34. PubMed ID: 9669245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical prognosis of moderate restenosis after percutaneous transluminal coronary angioplasty].
    Fukuzawa S; Ozawa S; Katagiri M; Watanabe H
    J Cardiol; 1995 Feb; 25(2):63-8. PubMed ID: 7897608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with Abciximab: early and six-month outcome.
    Murdock DK; Logemann T; Hoffmann MT; Olson KJ; Engelmeier RS
    Cathet Cardiovasc Diagn; 1997 Oct; 42(2):173-9. PubMed ID: 9328702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregability and occurrence of restenosis following coronary angioplasty.
    Goel PK; Shahi M; Agarwal AK; Srivastava S; Seth PK
    Int J Cardiol; 1997 Aug; 60(3):227-31. PubMed ID: 9261632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
    Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
    Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis, and long-term clinical follow-up.
    Ivanhoe RJ; Weintraub WS; Douglas JS; Lembo NJ; Furman M; Gershony G; Cohen CL; King SB
    Circulation; 1992 Jan; 85(1):106-15. PubMed ID: 1728439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.